Summary
The Evaluating Neuroprotection in Aneurysm Coiling Therapy trial [ENACT; NCT00728182] showed that the novel agent NA-1 may be a useful treatment for stroke and ruptured aneurysm patients.
- Cerebrovascular Disease Clinical Trials
- Interventional Techniques & Devices
- Ischemia
- © 2012 MD Conference Express®
Tools
Novel Agent NA-1 Proves That Ischemic Neuroprotection is Possible in Older Patients
Permalink:
